INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2018

A meta-analysis of 228 trials found that probiotic efficacy is both strain-specific and disease-specific.

A systematic review and meta-analysis of 228 trials (1970-2017) assessed whether probiotic strains have strain- and disease-specific efficacy in preventive and treatment indications with at least two randomized controlled trials per indication. Significant efficacy evidence was found for 7 (70%) of probiotic strain(s) among four preventive indications and 11 (65%) probiotic strain(s) among five treatment indications. For preventing adult antibiotic-associated diarrhea, specific Lactobacillus preparations (such as Bio-K+, Actimel, and L. reuteri 55730) demonstrated efficacy while other Lactobacillus strains did not. Significant disease-specific variations in efficacy were also shown for L. rhamnosus GG and Saccharomyces boulardii CNCM I-745, among other strains.

Study type
Systematic review and meta-analysis
Who was studied
Participants across 228 randomized controlled trials
What was measured
Strain-specific and disease-specific probiotic efficacy across clinical indications

THE PAPER

Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.

McFarland LV, Evans CT, Goldstein EJC. Front Med (Lausanne), 2018.

PubMed 29868585 ↗DOI 10.1080/03007995.2017.1322571 ↗

Gut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.